Sichuan Hebang Biotechnology Corporation Limited (SHA: 603077)

Sichuan Hebang Biotechnology Corporation Statistics

Total Valuation

Sichuan Hebang Biotechnology Corporation has a market cap or net worth of CNY 16.19 billion. The enterprise value is 17.11 billion.

Market Cap	16.19B
Enterprise Value	17.11B

Important Dates

The next estimated earnings date is Monday, October 21, 2024.

Earnings Date	Oct 21, 2024
Ex-Dividend Date	n/a

Share Statistics

Sichuan Hebang Biotechnology Corporation has 8.10 billion shares outstanding. The number of shares has decreased by -2.16% in one year.

Shares Outstanding	8.10B
Shares Change (YoY)	-2.16%
Shares Change (QoQ)	+1.15%
Owned by Insiders (%)	5.90%
Owned by Institutions (%)	3.21%
Float	4.75B

Valuation Ratios

The trailing PE ratio is 19.81.

PE Ratio	19.81
Forward PE	n/a
PS Ratio	1.78
PB Ratio	0.86
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.53, with an EV/FCF ratio of -14.77.

EV / Earnings	19.92
EV / Sales	1.79
EV / EBITDA	8.53
EV / EBIT	17.24
EV / FCF	-14.77

Financial Position

The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.17.

Current Ratio	1.96
Quick Ratio	1.08
Debt / Equity	0.17
Debt / EBITDA	1.67
Debt / FCF	-2.89
Interest Coverage	28.90

Financial Efficiency

Return on equity (ROE) is 4.36% and return on invested capital (ROIC) is 2.79%.

Return on Equity (ROE)	4.36%
Return on Assets (ROA)	2.48%
Return on Capital (ROIC)	2.79%
Revenue Per Employee	1.34M
Profits Per Employee	119,819
Employee Count	7,169
Asset Turnover	0.38
Inventory Turnover	1.97

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.36% in the last 52 weeks. The beta is 0.32, so Sichuan Hebang Biotechnology Corporation's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	-6.36%
50-Day Moving Average	1.73
200-Day Moving Average	2.05
Relative Strength Index (RSI)	69.39
Average Volume (20 Days)	87,618,314

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sichuan Hebang Biotechnology Corporation had revenue of CNY 9.58 billion and earned 858.98 million in profits. Earnings per share was 0.10.

Revenue	9.58B
Gross Profit	1.61B
Operating Income	992.67M
Pretax Income	1.05B
Net Income	858.98M
EBITDA	1.99B
EBIT	992.67M
Earnings Per Share (EPS)	0.10

Balance Sheet

The company has 3.06 billion in cash and 3.34 billion in debt, giving a net cash position of -283.35 million or -0.04 per share.

Cash & Cash Equivalents	3.06B
Total Debt	3.34B
Net Cash	-283.35M
Net Cash Per Share	-0.04
Equity (Book Value)	19.62B
Book Value Per Share	2.32
Working Capital	5.44B

Cash Flow

In the last 12 months, operating cash flow was -362.29 million and capital expenditures -796.72 million, giving a free cash flow of -1.16 billion.

Operating Cash Flow	-362.29M
Capital Expenditures	-796.72M
Free Cash Flow	-1.16B
FCF Per Share	-0.14

Margins

Gross margin is 16.79%, with operating and profit margins of 10.36% and 8.96%.

Gross Margin	16.79%
Operating Margin	10.36%
Pretax Margin	10.98%
Profit Margin	8.96%
EBITDA Margin	20.80%
EBIT Margin	10.36%
FCF Margin	-12.10%

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 1.93%.

Dividend Per Share	0.04
Dividend Yield	1.93%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	8.74%
Buyback Yield	2.16%
Shareholder Yield	4.10%
Earnings Yield	5.05%
FCF Yield	-7.16%

Stock Splits

The last stock split was on July 5, 2017. It was a forward split with a ratio of 2.2.

Last Split Date	Jul 5, 2017
Split Type	Forward
Split Ratio	2.2

Scores

Sichuan Hebang Biotechnology Corporation has an Altman Z-Score of 3.1.

Altman Z-Score	3.1
Piotroski F-Score	n/a